Role of capsule endoscopy in suspected celiac disease: A European multi-centre study

doi:10.3748/wjg.v23.i4.703

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12077)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

719

WORD

368

HTML

7090

Figures (1-3)

392

Tables (1-3)

217

Sum=8786

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1299

Download

1992

Sum=3291

Jan 28, 2017 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Jan 28, 2017; 23(4): 703-711
Published online Jan 28, 2017. doi: 10.3748/wjg.v23.i4.703

Table 3 Modifications and response to the gluten-free diet in the different subgroups of patients n (%)

Subgroup¹	Therapeutic yield	GFD Indicated	GFD removed	Responded to GFD	Responded to the withdrawal
I (n =19)	16 (84.2)	12 (63.2)	1 (5.3)	8 (66.7)	0
II (n = 39)	31 (79.5)	27 (69.2)	0	18 (66.7)	-
III (n = 6)	6 (100)	5 (83.3)	0	4 (80)	-
IV (n = 99)	64 (64.7)	41 (41.4)	3 (3.1)	39 (95.1)	3 (100)

¹Group-I: seronegative celiac disease; Group-II: Positive serology with no atrophy; Group-III: Contraindications or refusal to undergo gastroscopy; Group-IV: Seronegative patients without atrophy, with clinical digestive symptoms and/or anaemia. GFD: Gluten-free diet.

Citation: Luján-Sanchis M, Pérez-Cuadrado-Robles E, García-Lledó J, Juanmartiñena Fernández JF, Elli L, Jiménez-García VA, Egea-Valenzuela J, Valle-Muñoz J, Carretero-Ribón C, Fernández-Urién-Sainz I, López-Higueras A, Alonso-Lázaro N, Sanjuan-Acosta M, Sánchez-Ceballos F, Rosa B, González-Vázquez S, Branchi F, Ruano-Díaz L, Prieto-de-Frías C, Pons-Beltrán V, Borque-Barrera P, González-Suárez B, Xavier S, Argüelles-Arias F, Herrerías-Gutiérrez JM, Pérez-Cuadrado-Martínez E, Sempere-García-Argüelles J. Role of capsule endoscopy in suspected celiac disease: A European multi-centre study. World J Gastroenterol 2017; 23(4): 703-711
URL: https://www.wjgnet.com/1007-9327/full/v23/i4/703.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i4.703